Loading…
Arkema is studying a doubling of thiochemicals capacity at its Beaumont, Texas site to supply Novus International's proposed methionine hydroxy analogue plant. Arkema also plans to double methyl mercaptan output at Kerteh, Malaysia by 2020.
A final investment decision is expected at the end of 2018, with the Texas plant due by summer 2021.
Expanded methionine intermediate supply is a longer-term bearish factor for methionine prices, and it supports the case for rising methionine output tied to growing feed demand.
chemanager-online.comJun 8, 2018Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
